FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/06/2026
Voltar para busca
Dado oficial do USPTO
SNAP LNP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SNAP LNP
ST13
US500000079408855Classe
1, 5, 42, 44
Pedido
79408855
Registro
8163914
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
11/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
26/04/2024
Data de registro
10/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/03/2026
Última transação
11/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
DE
Examinador
STIGLITZ, SUSAN R
Unidade examinadora
L90
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Ethris GmbH
Representantes
Catherine F. Hoffman Baker, Donelson, Bearman, Caldwell & Ber
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Preservatives for use in the pharmaceutical industry; chemicals for use in industry and science; chemicals for biological preparations regarding use in industry and science; biological preparations for use in industry and science; nucleic acids for use in industry and scienceother than for medical or veterinary purposes; organic chemicals for use in industry and science; industrial organic chemicals for use in industry and science; organic chemicals for the industry; detergents for use in the manufacture of nanocarriers and nanoparticles and their formulationsof formulations comprising nucleic acidsdetergents for use in industrial manufacturing processes; salts for industrial purposes; chemical and organic compositions being organic chemicals for use in the manufacture of food and beverages; aqueous chemical compositionscompositions comprising nucleic acids and nanocarriers or nanoparticles and their formulations for use in industry and science; Triglycerides being chemical additives for use in the manufacture of medicines and medical formulations composed of medicines comprising nucleic acids and/or nanocarriers or nanoparticles and their formulations; nucleic recombinant acids for use in industry and scienceother than for medical or veterinary purposes; pyrimidine; lipids used in the manufacture of pharmaceuticals and cosmeticsincluding lipid nanoparticleslipid formulations for research purposes and laboratory use; polymer compositions used in the manufacture of commercial and industrial goods especially of medicines or pharmaceutical preparationshydrosoluble polymerspolymer dispersionsbiodegradable polymer compositionshydrogel polymer coatingscationic polymerspolymer solutionsaqueous polymer dispersions; fatty acid esters for industrial purposesfor use in medicines and/or pharmaceutical formulations; all of the aforementioned goods not for veterinary use.
Classe 5
Pharmaceuticalspharmaceutical drugs and pharmaceutical preparations for immunization and/or for the prevention or treatment of diseases and conditions affecting various body systemsrespiratory system diseaseslung diseasesairway diseasesnasal diseaseslung viral diseaseslung ciliopathieslung autoimmune diseasespathogen infectionsviral infectionsbacterial infectionsfungal infectionsparasitic infectionspathogen-caused diseasesrespiratory system diseasesviral induced asthmacongenital diseasesautoimmune diseasesimmune system diseasesnervous system diseasesneurodegenerative diseasesneuroinflammatory diseasesneuropathiescirculatory system diseasescardiovascular diseasesblood disordersvascular diseasesdigestive system diseasesgastrointestinal diseasesliver diseasespancreatic diseasesurinary system diseaseskidney diseasesbladder disordersurinary tract infectionsreproductive system diseasesinfertilityhormonal disordersreproductive tract infectionsmuscular diseasesmuscular dystrophiesmyopathiesinflammatory muscle diseasestendon diseasesbone diseasesosteoporosisosteoarthritisteeth diseases and decaybone metabolic disordersskin diseasesdermatological conditionsinflammatory skin diseasesskin infectionsendocrine system diseasesdiabetesthyroid disordersadrenal gland disordersmetabolic diseasesgenetic metabolic disordersacquired metabolic syndromeslymphatic system diseaseslymphedemalymphatic infectionspsychiatric conditionsmental health conditionsmood disordersanxiety disorderspsychotic disordersocular diseasesglaucomamacular degenerationocular infectionsearnose and throat (ENT) diseasesrhinitissinusitisotitisthroat infectionshematologic diseasesanemiahemophiliaclotting disordershair restorationfor pain management for chronic or terminal illnesses; dermatological pharmaceutical products; pharmaceutical preparations for use in dermatology; anti-diabetic pharmaceuticals; cardiovascular pharmaceuticals; injectable pharmaceuticals for treatment and/or prevention of diseases and conditions affecting various body systemsrespiratory system diseaseslung diseasesairway diseasesnasal diseaseslung viral diseaseslung ciliopathieslung autoimmune diseasespathogen infectionsviral infectionsbacterial infectionsfungal infectionsparasitic infectionspathogen-caused diseasesrespiratory system diseasesviral induced asthmacongenital diseasesprimary ciliary dyskinesiaautoimmune diseasesimmune system diseasesnervous system diseasesneurodegenerative diseasesneuroinflammatory diseasesneuropathiescirculatory system diseasescardiovascular diseasesblood disordersvascular diseasesdigestive system diseasesgastrointestinal diseasesliver diseasespancreatic diseasesurinary system diseaseskidney diseasesbladder disordersurinary tract infectionsreproductive system diseasesinfertilityhormonal disordersreproductive tract infectionsmuscular diseasesmuscular dystrophiesmyopathiesinflammatory muscle diseasestendon diseasesbone diseasesosteoporosisosteoarthritisbone fractureteeth diseases and decaybone metabolic disordersskin diseasesdermatological conditionsinflammatory skin diseasesskin infectionsendocrine system diseasesdiabetesthyroid disordersadrenal gland disordersmetabolic diseasesgenetic metabolic disordersacquired metabolic syndromeslymphatic system diseaseslymphedemalymphatic infectionspsychiatric conditionsmental health conditionsmood disordersanxiety disorderspsychotic disordersocular diseasesglaucomamacular degenerationocular infectionsearnose and throat (ENT) diseasesrhinitissinusitisotitisthroat infectionshematologic diseasesanemiahemophiliaclotting disordershair restorationfor pain management for chronic or terminal illnesses; tissue-regenerative pharmaceutical preparations for the treatment of respiratory diseases and disordersdermatological diseases and disordersmusculoskeletal and orthopedic diseases and disordersdiabetesdental and periodontal diseases and disorderscardiovascular and neurological diseases and disordersmuscular and joint painophthalmic diseases and disordersgynecological and obstetric diseases and disordersorgan repair and regenerationin the nature of liver regenerationkidney regenerationintestinal tissue repair; tissue-regenerative pharmaceutical preparations for the treatment of rare diseases involving tissue degeneration or defectssuch as epidermolysis bullosaosteogenesis imperfectaamyotrophic lateral sclerosis (ALS); cardiovascular pharmaceutical preparations; antibacterial pharmaceuticals; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; inhalant anaesthetic preparations; inhalers for medical purposessold filled with pharmaceutical preparations for treating respiratory diseases and disorders; medicated dental preparations for regeneration of teethperiodontal tissuesdental pulptreatment of alveolar bone loss; dental articlesnamely materials for tooth restorationdental cementsmaterials for dental fillingsbone fillers consisting of living materials as well as bone growth media consisting of biological materials for medical purposes; medicated dentifrices; dietary supplements and dietetic preparations; pharmaceutical preparations for the treatment of kidney diseases; respiratory stimulants; compoundspharmaceutical preparations for treating correlated pulmonary syndromes; medicines for the treatment of cardiovascular and cerebrovascular diseases; fertility enhancement preparations; pharmaceutical preparations for treatment and prevention of immune system and autoimmune system related diseases and disorders; pharmaceuticals and medical preparations comprising nucleic acids for the immunization and/or prevention or treatment of diseases and conditions affecting various body systemsrespiratory system diseaseslung diseasesairway diseasesnasal diseaseslung viral diseaseslung ciliopathieslung autoimmune diseasespathogen infectionsviral infectionsbacterial infectionsfungal infectionsparasitic infectionspathogen-caused diseasesrespiratory system diseasesviral induced asthmacongenital diseasesautoimmune diseasesimmune system diseasesnervous system diseasesneurodegenerative diseasesneuroinflammatory diseasesneuropathiescirculatory system diseasescardiovascular diseasesblood disordersvascular diseasesdigestive system diseasesgastrointestinal diseasesliver diseasespancreatic diseasesurinary system diseaseskidney diseasesbladder disordersurinary tract infectionsreproductive system diseasesinfertilityhormonal disordersreproductive tract infectionsmuscular diseasesmuscular dystrophiesmyopathiesinflammatory muscle diseasestendon diseasesbone diseasesosteoporosisosteoarthritisbone fractureteeth diseases and decaybone metabolic disordersskin diseasesdermatological conditionsinflammatory skin diseasesskin infectionsendocrine system diseasesdiabetesthyroid disordersadrenal gland disordersmetabolic diseasesgenetic metabolic disordersacquired metabolic syndromeslymphatic system diseaseslymphedemalymphatic infectionspsychiatric conditionsmental health conditionsmood disordersanxiety disorderspsychotic disordersocular diseasesglaucomamacular degenerationocular infectionsearnose and throat (ENT) diseasesrhinitissinusitisotitisthroat infectionshematologic diseasesanemiahemophiliaclotting disordershair restorationfor pain management for chronic or terminal illnesses; pharmaceuticals (MRNA) for the treatment of lung diseases; pharmaceuticals for the treatment of congenital diseasesin particular lung congenital diseases and/or autoimmune diseases; chemicals used for delivering nucleic acids to cellsin particular lipids for the delivery of nucleic acids for medical use; chemicals used for stabilizing nucleic acid delivery systemsin particular for stabilizing lipid nanoparticles for medical use; pharmaceutical preparationsdrug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics for medical use; pharmaceutical preparations comprised of nucleic acidsmessenger RNAlipid nanoparticles for immunization and/or prevention or treatment of diseases and conditions affecting various body systemsrespiratory system diseaseslung diseasesairway diseasesnasal diseaseslung viral diseaseslung ciliopathieslung autoimmune diseasespathogen infectionsviral infectionsbacterial infectionsfungal infectionsparasitic infectionspathogen-caused diseasesrespiratory system diseasesviral induced asthmacongenital diseasesautoimmune diseasesimmune system diseasesnervous system diseasesneurodegenerative diseasesneuroinflammatory diseasesneuropathiescirculatory system diseasescardiovascular diseasesblood disordersvascular diseasesdigestive system diseasesgastrointestinal diseasesliver diseasespancreatic diseasesurinary system diseaseskidney diseasesbladder disordersurinary tract infectionsreproductive system diseasesinfertilityhormonal disordersreproductive tract infectionsmuscular diseasesmuscular dystrophiesmyopathiesinflammatory muscle diseasestendon diseasesbone diseasesosteoporosisosteoarthritisbone fractureteeth diseases and decaybone metabolic disordersskin diseasesdermatological conditionsinflammatory skin diseasesskin infectionsendocrine system diseasesdiabetesthyroid disordersadrenal gland disordersmetabolic diseasesgenetic metabolic disordersacquired metabolic syndromeslymphatic system diseaseslymphedemalymphatic infectionspsychiatric conditionsmental health conditionsmood disordersanxiety disorderspsychotic disordersocular diseasesglaucomamacular degenerationocular infectionsearnose and throat (ENT) diseasesrhinitissinusitisotitisthroat infectionshematologic diseasesanemiahemophiliaclotting disordershair restorationfor pain management for chronic or terminal illnesses; pharmaceutical preparations comprised of lipid nanoparticles for immunization and/or prevention or treatment of diseases and conditions affecting various body systemsrespiratory system diseaseslung diseasesairway diseasesnasal diseaseslung viral diseaseslung ciliopathieslung autoimmune diseasespathogen infectionsviral infectionsbacterial infectionsfungal infectionsparasitic infectionspathogen-caused diseasesrespiratory system diseasesviral induced asthmacongenital diseasesautoimmune diseasesimmune system diseasesnervous system diseasesneurodegenerative diseasesneuroinflammatory diseasesneuropathiescirculatory system diseasescardiovascular diseasesblood disordersvascular diseasesdigestive system diseasesgastrointestinal diseasesliver diseasespancreatic diseasesurinary system diseaseskidney diseasesbladder disordersurinary tract infectionsreproductive system diseasesinfertilityhormonal disordersreproductive tract infectionsmuscular diseasesmuscular dystrophiesmyopathiesinflammatory muscle diseasestendon diseasesbone diseasesosteoporosisosteoarthritisbone fractureteeth diseases and decaybone metabolic disordersskin diseasesdermatological conditionsinflammatory skin diseasesskin infectionsendocrine system diseasesdiabetesthyroid disordersadrenal gland disordersmetabolic diseasesgenetic metabolic disordersacquired metabolic syndromeslymphatic system diseaseslymphedemalymphatic infectionspsychiatric conditionsmental health conditionsmood disordersanxiety disorderspsychotic disordersocular diseasesglaucomamacular degenerationocular infectionsearnose and throat (ENT) diseasesrhinitissinusitisotitisthroat infectionshematologic diseasesanemiahemophiliaclotting disordershair restorationfor pain management for chronic or terminal illnesses; autoantigenspharmaceutical preparations for the treatment and prevention of human autoimmune diseases and cancer; vaccines; vaccine preparations; vaccine adjuvants; vaccines against pneumococcal infections; viral vaccines; human vaccine preparations; vaccines against flu; oral vaccine preparations; antiviral drugs for treating influenza; vaccines for human use; pharmaceutical preparations in the nature of fat emulsions composed of nucleic acids and/or nanocarriersintravenous lipid emulsions for use with medical infusions; aerosols formulations and spray formulations for medical usemRNA deliveryvaccination and treatment of respiratory system diseases; aerosols formulations and spray formulations for medical useinhaled mRNA drugs; aerosols formulations and spray formulations for medical useinhaled vaccines; aerosols formulations and spray formulations for medical useinhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Medicinal healthcare preparations namely preparations comprising nucleic acids and/or nanocarriers or nanoparticles and its formulationsaerosols formulationsspray formulations; medicinal preparations and substances for treating diseases and conditions affecting various body systemsrespiratory system diseaseslung diseasesairway diseasesnasal diseaseslung viral diseaseslung ciliopathieslung autoimmune diseasespathogen infectionsviral infectionsbacterial infectionsfungal infectionsparasitic infectionspathogen-caused diseasesrespiratory system diseasesviral induced asthmacongenital diseasesautoimmune diseasesimmune system diseasesnervous system diseasesneurodegenerative diseasesneuroinflammatory diseasesneuropathiescirculatory system diseasescardiovascular diseasesblood disordersvascular diseasesdigestive system diseasesgastrointestinal diseasesliver diseasespancreatic diseasesurinary system diseaseskidney diseasesbladder disordersurinary tract infectionsreproductive system diseasesinfertilityhormonal disordersreproductive tract infectionsmuscular diseasesmuscular dystrophiesmyopathiesinflammatory muscle diseasestendon diseasesbone diseasesosteoporosisosteoarthritisteeth diseases and decaybone metabolic disordersbone fractureskin diseasesdermatological conditionsinflammatory skin diseasesskin infectionsendocrine system diseasesdiabetesthyroid disordersadrenal gland disordersmetabolic diseasesgenetic metabolic disordersacquired metabolic syndromeslymphatic system diseaseslymphedemalymphatic infectionspsychiatric conditionsmental health conditionsmood disordersanxiety disorderspsychotic disordersocular diseasesglaucomamacular degenerationocular infectionsearnose and throat (ENT) diseasesrhinitissinusitisotitisthroat infectionshematologic diseasesanemiahemophiliaclotting disordershair restorationfor pain management for chronic or terminal illnesses; Medicinal infusions for treating diseases and conditions affecting various body systemsrespiratory system diseaseslung diseasesairway diseasesnasal diseaseslung viral diseaseslung ciliopathieslung autoimmune diseasespathogen infectionsviral infectionsbacterial infectionsfungal infectionsparasitic infectionspathogen-caused diseasesrespiratory system diseasesviral induced asthmacongenital diseasesautoimmune diseasesimmune system diseasesnervous system diseasesneurodegenerative diseasesneuroinflammatory diseasesneuropathiescirculatory system diseasescardiovascular diseasesblood disordersvascular diseasesdigestive system diseasesgastrointestinal diseasesliver diseasespancreatic diseasesurinary system diseaseskidney diseasesbladder disordersurinary tract infectionsreproductive system diseasesinfertilityhormonal disordersreproductive tract infectionsmuscular diseasesmuscular dystrophiesmyopathiesinflammatory muscle diseasestendon diseasesbone diseasesosteoporosisosteoarthritisbone fractureteeth diseases and decaybone metabolic disordersskin diseasesdermatological conditionsinflammatory skin diseasesskin infectionsendocrine system diseasesdiabetesthyroid disordersadrenal gland disordersmetabolic diseasesgenetic metabolic disordersacquired metabolic syndromeslymphatic system diseaseslymphedemalymphatic infectionspsychiatric conditionsmental health conditionsmood disordersanxiety disorderspsychotic disordersocular diseasesglaucomamacular degenerationocular infectionsearnose and throat (ENT) diseasesrhinitissinusitisotitisthroat infectionshematologic diseasesanemiahemophiliaclotting disordershair restorationfor pain management for chronic or terminal illnesses; serotherapeutic medicines for passive immunitymodulating immune responsesconvalescent plasma therapiestreating autoimmune diseasesinflammatory conditionscancerviral infectionspreventing or treating allergic reactions; antiallergic medicines; nucleic acid sequences for medical purposes; biological preparationsnucleic acid sequences for medical purposes; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposesdrug delivery agents in the form of injectables that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposesdrug delivery agents in the form of parenteral formulations that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposesdrug delivery agents in the form of oral liquids that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposesdrug delivery agents in the form of powderstabletscapsules that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposesdrug delivery agents in the form of lyophilized compositions that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposesdrug delivery agents in the form of dry-powder formulations for airway delivery that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposesdrug delivery agents in the form of nasal sprays that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposesdrug delivery agents in the form of nebulized solutions that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposesdrug delivery agents in the form of aerosols that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposesdrug delivery agents in the form of topical formulations that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical purposesdrug delivery agents in the form of transdermal patches that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; transdermal patches featuring lipid nanoparticle substances and lipid nanoparticle preparations for medical purposesdrug delivery agents that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicines; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of injectables that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of parenteral formulations that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of oral liquids that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of powderstabletscapsules that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of lyophilized compositions that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of dry-powder formulations for airway delivery that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of nasal sprays that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of nebulized solutions that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of aerosols that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of topical formulations that facilitate delivery of nucleic acids; lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes in the form of transdermal patches that facilitate delivery of nucleic acids; transdermal patches featuring lipid nanoparticle substances and lipid nanoparticle preparations for medical and pharmaceutical purposes that facilitate delivery of nucleic acids; lipid nanoparticle materials in the nature of intravenous lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for vaccines; lipid nanoparticle materials in the nature of intramuscular lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for vaccines; lipid nanoparticle materials in the nature of subcutaneous lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for vaccines; lipid nanoparticle materials in the nature of oral lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for vaccines; lipid nanoparticle materials in the nature of inhaled lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for vaccines; lipid nanoparticle materials in the nature of instilled lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for vaccines; lipid nanoparticle materials in the nature of intravenous lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for antibiotics; lipid nanoparticle materials in the nature of intramuscular lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for antibiotics; lipid nanoparticle materials in the nature of subcutaneous lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for antibiotics; lipid nanoparticle materials in the nature of oral lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for antibiotics; lipid nanoparticle materials in the nature of inhaled lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for antibiotics; lipid nanoparticle materials in the nature of instilled lipid emulsions for carrying and delivery of biochemical and pharmaceutical substances for antibiotics; lipid nanoparticle preparations for medicinesfor stabilizing of chemicalbiochemicalbiological and pharmaceutical substances; acids for pharmaceutical purposesnamely nucleic acidsrecombinant nucleic acidsfatty acid estersphospholipidsIonizable Lipidscholesterol derivative acids; adjuvants for medical purposes; cellular function activating agents for medical purposes; chemical preparations for medical purposesfor diseases and conditions affecting various body systemsrespiratory system diseaseslung diseasesairway diseasesnasal diseaseslung viral diseaseslung ciliopathieslung autoimmune diseasespathogen infectionsviral infectionsbacterial infectionsfungal infectionsparasitic infectionspathogen-caused diseasesrespiratory system diseasesviral induced asthmacongenital diseasesautoimmune diseasesimmune system diseasesnervous system diseasesneurodegenerative diseasesneuroinflammatory diseasesneuropathiescirculatory system diseasescardiovascular diseasesblood disordersvascular diseasesdigestive system diseasesgastrointestinal diseasesliver diseasespancreatic diseasesurinary system diseaseskidney diseasesbladder disordersurinary tract infectionsreproductive system diseasesinfertilityhormonal disordersreproductive tract infectionsmuscular diseasesmuscular dystrophiesmyopathiesinflammatory muscle diseasestendon diseasesbone diseasesosteoporosisosteoarthritisteeth diseases and decaybone metabolic disordersbone fractureskin diseasesdermatological conditionsinflammatory skin diseasesskin infectionsendocrine system diseasesdiabetesthyroid disordersadrenal gland disordersmetabolic diseasesgenetic metabolic disordersacquired metabolic syndromeslymphatic system diseaseslymphedemalymphatic infectionspsychiatric conditionsmental health conditionsmood disordersanxiety disorderspsychotic disordersocular diseasesglaucomamacular degenerationocular infectionsearnose and throat (ENT) diseasesrhinitissinusitisotitisthroat infectionshematologic diseasesanemiahemophiliaclotting disordershair restorationfor pain management for chronic or terminal illnesses; nasal sprays for medical purposes; medicated nasal spray preparations; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; compounds being pharmaceutical preparations for treating cancer; all of the aforementioned goods not for veterinary use.
Classe 42
Research of pharmaceuticals; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical product researchdevelopmentevaluation services in the fields of medical therapiesimmunologyvaccinesbiotechnologynanotechnologygene therapylipidslipid formulationslipid nanoparticlesnucleic acidsincluding messenger rnadrug delivery agentsnucleic acid therapeuticssynthetic chemistry process technology; research and development of vaccines and medicines; vaccine research and development services; research and development services relating to vaccines; development of gene-based medicines; gene therapy research; research in the field of gene therapy; laboratory research in the field of gene expression; research in the field of gene editing technology; research and development services in the field of gene expression systems; advisory services relating to gene therapy research; biotechnology research; research and development in the pharmaceutical and biotechnology fields; biotechnology testingproduct testing for otherssuch as nucleic acids testingnanocarrier testingaerosol testingvaccine testing; scientific research relating to biology; scientific research in the field of genetics and genetic engineering; scientific research relating to molecular sciences; information on the subject of scientific research in the field of biochemistry and biotechnology; scientific research in the field of genetics; scientific research relating to genetics; all aforementioned services not in the veterinary field.
Classe 44
Preparation and dispensing of medications; fertility treatmentproviding health information in the field of fertility; human fertility treatment services; vaccination servicesadministering vaccines to patientstesting of vaccines; regenerative medicine services; dispensing of pharmaceuticals; medicalphysicalrehabilitationphysical therapy servicesrespiratory systemantiviralbonehearttendon therapy services; medical treatment servicesmedical treatment of diseases and conditions affecting various body systemsrespiratory system diseaseslung diseasesairway diseasesnasal diseaseslung viral diseaseslung ciliopathieslung autoimmune diseasespathogen infectionsviral infectionsbacterial infectionsfungal infectionsparasitic infectionspathogen-caused diseasesrespiratory system diseasesviral induced asthmacongenital diseasesautoimmune diseasesimmune system diseasesnervous system diseasesneurodegenerative diseasesneuroinflammatory diseasesneuropathiescirculatory system diseasescardiovascular diseasesblood disordersvascular diseasesdigestive system diseasesgastrointestinal diseasesliver diseasespancreatic diseasesurinary system diseaseskidney diseasesbladder disordersurinary tract infectionsreproductive system diseasesinfertilityhormonal disordersreproductive tract infectionsmuscular diseasesmuscular dystrophiesmyopathiesinflammatory muscle diseasestendon diseasesbone diseasesosteoporosisosteoarthritisteeth diseases and decaybone metabolic disordersskin diseasesdermatological conditionsinflammatory skin diseasesskin infectionsendocrine system diseasesdiabetesthyroid disordersadrenal gland disordersmetabolic diseasesgenetic metabolic disordersacquired metabolic syndromeslymphatic system diseaseslymphedemalymphatic infectionspsychiatric conditionsmental health conditionsmood disordersanxiety disorderspsychotic disordersocular diseasesglaucomamacular degenerationocular infectionsearnose and throat (ENT) diseasesrhinitissinusitisotitisthroat infectionshematologic diseasesanemiahemophiliaclotting disordershair restorationfor pain management for chronic or terminal illnesses; all of the aforementioned services not for the veterinary field.
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
23/04/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/04/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/04/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
10/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/01/2026
PUBO
PUBLISHED FOR OPPOSITION
20/01/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/01/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/12/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
15/12/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/11/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
16/06/2025
GNFR
FINAL REFUSAL E-MAILED
16/06/2025
CNFR
FINAL REFUSAL WRITTEN
16/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/05/2025
RFNT
REFUSAL PROCESSED BY IB
07/12/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/11/2024
RFRR
REFUSAL PROCESSED BY MPU
20/11/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/11/2024
CNRT
NON-FINAL ACTION WRITTEN
13/11/2024
DOCK
ASSIGNED TO EXAMINER
12/11/2024
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/11/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/11/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SNAP LNP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.